Atlas Trials

Randomized Withdrawal Study in Patients With Schizophrenia

Clinical trial NCT06961968 · RECRUITING

Trial details

NCT number
NCT06961968
Sponsor
Vanda Pharmaceuticals
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2025-05-14
Primary completion
2027-11-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.